 Thomas P Ahern, Sc.D.
| Title | Instructor in Medicine |
|---|
| Institution | Brigham and Women's Hospital |
|---|
| Department | Medicine |
|---|
| Address | Brigham and Women's Hospital
Channing Division of Network Medicine
181 Longwood Ave
Boston MA 02115
|
|---|
|
|
|
 Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
-
Lash TL, Ahern TP. Bias analysis to guide new data collection. Int J Biostat. 2012; 8(2).
-
Cronin-Fenton DP, Hellberg Y, Lauridsen KL, Ahern TP, Garne JP, Rosenberg C, Silliman RA, Sørensen HT, Lash TL, Hamilton-Dutoit S. Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer study. Acta Oncol. 2012 Feb; 51(2):254-61.
-
Ahern TP, Pedersen L, Sværke C, Rothman KJ, Sørensen HT, Lash TL. The association between vitamin K antagonist therapy and site-specific cancer incidence estimated by using heart valve replacement as an instrumental variable. Am J Epidemiol. 2011 Dec 15; 174(12):1382-90.
-
Ahern TP, Hankinson SE. Re: Use of archived specimens in evaluation of prognostic and predictive biomarkers. J Natl Cancer Inst. 2011 Oct 19; 103(20):1558-9; author reply 1559-60.
-
Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sørensen HT, Lash TL. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst. 2011 Oct 5; 103(19):1461-8.
-
Ahern TP, Christensen M, Cronin-Fenton DP, Lunetta KL, Søiland H, Gjerde J, Garne JP, Rosenberg CL, Silliman RA, Sørensen HT, Lash TL, Hamilton-Dutoit S. Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors. Cancer Epidemiol Biomarkers Prev. 2011 Sep; 20(9):1937-43.
-
Lash TL, Cronin-Fenton D, Ahern TP, Rosenberg CL, Lunetta KL, Silliman RA, Garne JP, Sørensen HT, Hellberg Y, Christensen M, Pedersen L, Hamilton-Dutoit S. CYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark. J Natl Cancer Inst. 2011 Mar 16; 103(6):489-500.
-
Lash TL, Cronin-Fenton D, Ahern TP, Rosenberg CL, Lunetta KL, Silliman RA, Hamilton-Dutoit S, Garne JP, Ewertz M, Sørensen HT, Pedersen L. Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen. Acta Oncol. 2010 Apr; 49(3):305-12.
-
Ahern TP, Lash TL, Egan KM, Baron JA. Lifetime tobacco smoke exposure and breast cancer incidence. Cancer Causes Control. 2009 Dec; 20(10):1837-44.
-
Lee JC, Ahern TP, Chaves FP, Quillen K. Utility of hematologic and volume, conductivity, and scatter parameters from umbilical cord blood in predicting chorioamnionitis. Int J Lab Hematol. 2010 Jun; 32(3):351-9.
-
Ahern TP, Pedersen L, Cronin-Fenton DP, Sørensen HT, Lash TL. No increase in breast cancer recurrence with concurrent use of tamoxifen and some CYP2D6-inhibiting medications. Cancer Epidemiol Biomarkers Prev. 2009 Sep; 18(9):2562-4.
-
Ahern TP, Bosco JL, Silliman RA, Yood MU, Field TS, Wei F, Lash TL. Potential misinterpretations caused by collapsing upper categories of comorbidity indices: An illustration from a cohort of older breast cancer survivors. Clin Epidemiol. 2009; 1:93-100.
-
Ahern TP, Lash TL, Thwin SS, Silliman RA. Impact of acquired comorbidities on all-cause mortality rates among older breast cancer survivors. Med Care. 2009 Jan; 47(1):73-9.
-
Ahern TP, Lash TL, Sørensen HT, Pedersen L. Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study. Breast Cancer Res. 2008; 10(6):R102.
-
Lash TL, Ahern TP, Cronin-Fenton D, Garne JP, Hamilton-Dutoit S, Sørensen HT. Comment on 'Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy'. Cancer Sci. 2008 Aug; 99(8):1706-7.
-
Lash TL, Pedersen L, Cronin-Fenton D, Ahern TP, Rosenberg CL, Lunetta KL, Silliman RA, Hamilton-Dutoit S, Garne JP, Ewertz M, Sørensen HT. Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram. Br J Cancer. 2008 Aug 19; 99(4):616-21.
-
Ahern TP, Larsson H, Garne JP, Cronin-Fenton DP, Sørensen HT, Lash TL. Trends in breast-conserving surgery in Denmark, 1982-2002. Eur J Epidemiol. 2008; 23(2):109-14.
-
Balding J, Livingstone WJ, Pittock SJ, Mynett-Johnson L, Ahern T, Hodgson A, Smith OP. The IL-6 G-174C polymorphism may be associated with ischaemic stroke in patients without a history of hypertension. Ir J Med Sci. 2004 Oct-Dec; 173(4):200-3.
This graph shows the total number of publications by year.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
|
Ahern's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|